Journal Article Summary
The article investigates the effectiveness of a progestin-only contraceptive pill (POP), specifically norgestrel 75 mcg, in preventing pregnancy when users experience lapses in adherence, such as taking the pill late or missing a dose. This research is significant because while POPs are generally safe for most women, understanding how missed or delayed doses affect their contraceptive efficacy is crucial, especially if these pills become available over the counter. Current guidelines suggest that taking a POP more than three hours late is considered a missed pill, but there is limited data on how this impacts pregnancy prevention.
The study is designed as a multicenter, randomized, crossover trial involving reproductive-aged women with regular menstrual cycles. Participants will take norgestrel daily for three treatment cycles, during which they will experience both perfect adherence and scenarios of delayed or missed doses. The researchers will monitor cervical mucus characteristics and ovarian activity through ultrasound and blood tests to assess how these factors change with adherence lapses compared to regular use.
Limitations of the study include the exclusion of women with a BMI over 32 and the inability to ethically assess actual pregnancy rates due to potential risks. Participants are expected to discuss their contraceptive options and adherence challenges with healthcare professionals, especially if considering over-the-counter access to POPs. Understanding the implications of missed or delayed doses can help users make informed decisions about their contraceptive methods and overall reproductive health.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Edelman Alison, Hemon Agnes, Creinin Mitchell, Borensztein Pascale, Scherrer Bruno, Glasier Anna. Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study. JMIR Research Protocols 2021. DOI: 10.2196/29208. PMID: 33970869. PMCID: PMC8262664.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive --- Perrigo
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive --- Perrigo is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. No prescription required for eligible over-the-counter purchases.
